Barlita, Marjorie .
HRN: 22-60-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/14/2023
CEFUROXIME 1.5GM (VIAL)
05/14/2023
05/15/2023
IV
1.5gram
Q 8hrs X 3 Doses
Primary LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes